Boisteau E, Posseme C, Di Modugno F, et al. Anterior gradient proteins in gastrointestinal cancers: from cell biology to pathophysiology. Oncogene 2022;41:4673-85.
Obacz J, Sommerova L, Sicari D, et al. Extracellular AGR3 regulates breast cancer cells migration via Src signaling. Oncol Lett 2019;18:4449-56.
Fessart D, Domblides C, Avril T, et al. Secretion of protein disulphide isomerase AGR2 confers tumorigenic properties. Elife 2016;5:e13887.
Maurel M, Obacz J, Avril T, et al. Control of anterior gradient 2 (AGR2) dimerization links endoplasmic reticulum proteostasis to infammation. EMBO Mol Med 2019;11.
Merugu SB, Zhou B, Mangukiya HB, et al. Extracellular AGR2 activates neighboring fbroblasts through endocytosis and direct binding to ß-catenin that requires AGR2 dimerization and adhesion domains. Biochem Biophys Res Commun 2021;573:86-92.
Vieujean S, Hu S, Bequet E, et al. Potential role of epithelial endoplasmic reticulum stress and anterior gradient protein 2 homologue in crohn's disease fbrosis. J Crohns Colitis 2021;15:1737-50.
Uhlén M, Fagerberg L, Hallström BM, et al. Proteomics. tissue-based map of the human proteome. Science 2015;347:1260419.
Riener M-O, Thiesler T, Hellerbrand C, et al. Loss of anterior gradient-2 expression is an independent prognostic factor in colorectal carcinomas. Eur J Cancer 2014;50:1722-30.
Tian S, Hu J, Tao K, et al. Secreted AGR2 promotes invasion of colorectal cancer cells via Wnt11-mediated non-canonical Wnt signaling. Exp Cell Res 2018;364:198-207.
Fessart D, Mahouche I, Brouste V. Anterior gradient-2 (AGR2) is overexpressed in colon cancer and is a potential biomarker of microsatellite instability (MSI) tumors. bioRxiv 2022 https://doi.org/10.1101/2021. 09.07.459258
